Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Dynamic nuclear envelope phenotype in rats overexpressing mutated human torsinA protein.

Yu-Taeger L, Gaiser V, Lotzer L, Roenisch T, Fabry BT, Stricker-Shaver J, Casadei N, Walter M, Schaller M, Riess O, Nguyen HP, Ott T, Grundmann-Hauser K.

Biol Open. 2018 May 8. pii: bio.032839. doi: 10.1242/bio.032839. [Epub ahead of print]


Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease.

Novati A, Hentrich T, Wassouf Z, Weber JJ, Yu-Taeger L, Déglon N, Nguyen HP, Schulze-Hentrich JM.

Sci Rep. 2018 Apr 11;8(1):5803. doi: 10.1038/s41598-018-24243-z.


Genetic Rodent Models of Huntington Disease.

Stricker-Shaver J, Novati A, Yu-Taeger L, Nguyen HP.

Adv Exp Med Biol. 2018;1049:29-57. doi: 10.1007/978-3-319-71779-1_2.


Altered reactivity of central amygdala to GABAAR antagonist in the BACHD rat model of Huntington disease.

Lamirault C, Yu-Taeger L, Doyère V, Riess O, Nguyen HP, El Massioui N.

Neuropharmacology. 2017 Sep 1;123:136-147. doi: 10.1016/j.neuropharm.2017.05.032. Epub 2017 Jun 3.


Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels.

Yu-Taeger L, Bonin M, Stricker-Shaver J, Riess O, Nguyen HH.

Neuropharmacology. 2017 May 1;117:260-272. doi: 10.1016/j.neuropharm.2017.01.029. Epub 2017 Jan 30.


Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease.

El Massioui N, Lamirault C, Yagüe S, Adjeroud N, Garces D, Maillard A, Tallot L, Yu-Taeger L, Riess O, Allain P, Nguyen HP, von Hörsten S, Doyère V.

Front Behav Neurosci. 2016 Oct 26;10:204. eCollection 2016.


Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease.

Teo RT, Hong X, Yu-Taeger L, Huang Y, Tan LJ, Xie Y, To XV, Guo L, Rajendran R, Novati A, Calaminus C, Riess O, Hayden MR, Nguyen HP, Chuang KH, Pouladi MA.

Hum Mol Genet. 2016 Jul 1;25(13):2621-2632. Epub 2016 Apr 28.


Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.

Clemens LE, Weber JJ, Wlodkowski TT, Yu-Taeger L, Michaud M, Calaminus C, Eckert SH, Gaca J, Weiss A, Magg JC, Jansson EK, Eckert GP, Pichler BJ, Bordet T, Pruss RM, Riess O, Nguyen HP.

Brain. 2015 Dec;138(Pt 12):3632-53. doi: 10.1093/brain/awv290. Epub 2015 Oct 21.


Reduced impact of emotion on choice behavior in presymptomatic BACHD rats, a transgenic rodent model for Huntington Disease.

Adjeroud N, Yagüe S, Yu-Taeger L, Bozon B, Leblanc-Veyrac P, Riess O, Allain P, Nguyen HP, Doyère V, El Massioui N.

Neurobiol Learn Mem. 2015 Nov;125:249-57. doi: 10.1016/j.nlm.2015.10.003. Epub 2015 Oct 14.


Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.

Eckmann J, Clemens LE, Eckert SH, Hagl S, Yu-Taeger L, Bordet T, Pruss RM, Muller WE, Leuner K, Nguyen HP, Eckert GP.

Mol Neurobiol. 2014 Aug;50(1):107-18. doi: 10.1007/s12035-014-8663-3. Epub 2014 Mar 18.


Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease.

Gouarné C, Tardif G, Tracz J, Latyszenok V, Michaud M, Clemens LE, Yu-Taeger L, Nguyen HP, Bordet T, Pruss RM.

PLoS One. 2013 Nov 26;8(11):e81528. doi: 10.1371/journal.pone.0081528. eCollection 2013.


A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers.

Kelp A, Koeppen AH, Petrasch-Parwez E, Calaminus C, Bauer C, Portal E, Yu-Taeger L, Pichler B, Bauer P, Riess O, Nguyen HP.

J Neurosci. 2013 May 22;33(21):9068-81. doi: 10.1523/JNEUROSCI.5622-12.2013.


A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease.

Yu-Taeger L, Petrasch-Parwez E, Osmand AP, Redensek A, Metzger S, Clemens LE, Park L, Howland D, Calaminus C, Gu X, Pichler B, Yang XW, Riess O, Nguyen HP.

J Neurosci. 2012 Oct 31;32(44):15426-38. doi: 10.1523/JNEUROSCI.1148-12.2012.

Supplemental Content

Loading ...
Support Center